At 14:30 IST, the barometer index, the S&P BSE Sensex, was up 351.03 points or 0.58% to 60,444. The Nifty 50 index added 95.10 points or 0.53% to 17,989.95.
The broader market declined. The S&P BSE Mid-Cap index slipped 0.39% while the S&P BSE Small-Cap index shed 0.22%.
The market breadth was negative. On the BSE, 1532 shares rose, and 1931 shares fell. A total of 140 shares were unchanged.
Numbers to Track:
The yield on India's 10-year benchmark federal paper rose to 7.336 from its close of 7.327 recorded in the previous trading session.
In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 81.81, compared with its close of 81.5825 during the previous trading session.
MCX Gold futures for 3 February 2023 settlement lost 0.11% to Rs 56,421.
The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.09% to 102.29.
The United States 10-year bond yield rose 1.30% to 3.557.
In the commodities market, Brent crude for March 2023 settlement lost 49 cents or 0.57% to $84.79 a barrel.
Buzzing Index:
The Nifty Auto index rose 0.36% to 12,794.75. The index has declined 0.65% in the past trading session.
Tube Investments of India (up 1.15%), Eicher Motors (up 1.15%), Maruti Suzuki India (up 0.93%), Balkrishna Industries (up 0.86%), Tata Motors (up 0.81%), MRF (up 0.64%), Bajaj Auto (up 0.5%) and Bharat Forge (up 0.27%) advanced.
Stocks in Spotlight:
Mastek slipped 3.49% after the IT company's consolidated net profit tumbled 18.86% to Rs 64.18 crore as against Rs 79.10 crore recorded in Q2 FY23. In dollar terms, the firm's revenue was $80.1 million (CC growth of 3.1% QoQ and 20% YoY). The board of directors has recommended an interim dividend Rs 7 per equity share, which will be paid to the eligible shareholders within 30 days. The record date for the same is fixed on Wednesday, 1 February 2023.
Bank of India slumped 5.47%. The state-run bank's net profit increased 12% to Rs 1,151 crore on 26.3% rise in total income to Rs 14,159.60 in Q3 FY23 over Q3 FY22. Net interest income (NII) increased by 64% YoY to Rs 5,596 crore for Q3 FY23 as against Rs 3,408 crore for Q3 FY22. Net interest margin (NIM) (domestic) improved to 3.72% in Q3 FY23 as compared to 2.51% in Q3 FY22.
Glenmark Pharmaceuticals declined 0.75%. The drug maker launched the sacubitril + valsartan tablets in India, for the treatment of heart failure marketed under the brand name 'Sacu V'.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app